Picking up a robot in a syringe.
This tiny device is small enough to be injected into the eye without anesthetic. And could be how eye surgery is performed in the future according to its developers.
Goldman Sachs has published a research report on Ethan Allen Interiors (NYSE: ETH) after the company fell below Goldman and consensus estimates for the September quarter, and down significantly over this time in 2009.
In the report,...(read more
Ethan Allen Interiors, Inc (NYSE; ETH) has been upgraded from Neutral from Sell.
In a research note, Goldman Sachs writes,” We are upgrading ETH to Neutral from Sell. This story has under-delivered sharply over time, but today has...(read more